Frontlight ResearchEarly access
Trial site
ClinPhenomics CVC GmbH
- 14running trials
- 8closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Obesity8 trials
- Type 2 diabetes6 trials
- Heart failure5 trials
- Chronic kidney disease4 trials
- Familial hypercholesterolaemia2 trials
- Type 1 diabetes2 trials
- Aortic stenosis1 trial
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- High blood pressure1 trial
- Stroke1 trial
- Phase
- Phase 317 trials
- Phase 23 trials
- Phase 42 trials
- Status
- Completed8 trials
- Recruiting8 trials
- Active, not recruiting5 trials
- Not yet recruiting1 trial
- Lead sponsor
- Amgen4 trials
- AstraZeneca4 trials
- Amgen Inc.2 trials
- Boehringer Ingelheim2 trials
- Eli Lilly and Company2 trials
- and 6 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity5 recruiting
- Heart failure4 recruiting
- Type 2 diabetes3 recruiting
- Aortic stenosis1 recruiting
- Chronic kidney disease1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026